LINEAGE CELL THERAPEUTICS IN's ticker is LCTX and the CUSIP is 53566P109. A total of 117 filers reported holding LINEAGE CELL THERAPEUTICS IN in Q3 2021. The put-call ratio across all filers is 0.40 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $158,000 | +3.3% | 62,869 | +17.3% | 0.01% | +12.5% |
| Q2 2021 | $153,000 | +48.5% | 53,609 | +21.8% | 0.01% | +33.3% |
| Q1 2021 | $103,000 | +68.9% | 44,013 | +26.6% | 0.01% | +50.0% |
| Q4 2020 | $61,000 | -3.2% | 34,771 | -48.5% | 0.00% | +100.0% |
| Q3 2020 | $63,000 | -33.0% | 67,532 | -37.6% | 0.00% | 0.0% |
| Q2 2020 | $94,000 | -4.1% | 108,280 | -9.0% | 0.00% | -33.3% |
| Q1 2020 | $98,000 | -31.0% | 118,935 | -25.4% | 0.00% | +50.0% |
| Q4 2019 | $142,000 | – | 159,351 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 4,735,990 | $8,335,000 | 3.63% |
| BROADWOOD CAPITAL INC | 34,005,379 | $59,849,000 | 3.55% |
| Prescott General Partners LLC | 1,851,851 | $3,259,000 | 0.14% |
| Strategic Wealth Investment Group, LLC | 66,917 | $118,000 | 0.07% |
| Laidlaw Wealth Management LLC | 170,658 | $300,000 | 0.06% |
| Humankind Investments LLC | 26,737 | $47,000 | 0.05% |
| DAFNA Capital Management LLC | 80,000 | $141,000 | 0.04% |
| Beirne Wealth Consulting Services, LLC | 45,000 | $79,000 | 0.04% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 680,839 | $1,198,000 | 0.02% |
| Allegheny Financial Group LTD | 20,000 | $35,000 | 0.02% |